PD-1 blockade boosts radiofrequency ablation-elicited adaptive immune responses against tumor

被引：0
|
作者：
Jiang, J. [1 ]
Shi, L. [1 ]
Chen, L. [1 ]
Zhu, Y. [1 ]
Wu, C. [1 ]
Lu, B. [2 ]
机构：
[1] Soochow Univ, Dept Tumor Biol Treatment, Affiliated Hosp 3, Changzhou, Peoples R China
[2] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15213 USA
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2016年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
183
引用
收藏
页码：206 / 207
页数：2
相关论文
共 50 条
  • [1] PD-1 Blockade Boosts Radiofrequency Ablation-Elicited Adaptive Immune Responses against Tumor
    Shi, Liangrong
    Chen, Lujun
    Wu, Changping
    Zhu, Yibei
    Xu, Bin
    Zheng, Xiao
    Sun, Mingfen
    Wen, Wen
    Dai, Xichao
    Yang, Min
    Lv, Quansheng
    Lu, Binfeng
    Jiang, Jingting
    CLINICAL CANCER RESEARCH, 2016, 22 (05) : 1173 - 1184
  • [2] PD-1 blockade induces responses by inhibiting adaptive immune resistance
    Tumeh, Paul C.
    Harview, Christina L.
    Yearley, Jennifer H.
    Shintaku, I. Peter
    Taylor, Emma J. M.
    Robert, Lidia
    Chmielowski, Bartosz
    Spasic, Marko
    Henry, Gina
    Ciobanu, Voicu
    West, Alisha N.
    Carmona, Manuel
    Kivork, Christine
    Seja, Elizabeth
    Cherry, Grace
    Gutierrez, Antonio J.
    Grogan, Tristan R.
    Mateus, Christine
    Tomasic, Gorana
    Glaspy, John A.
    Emerson, Ryan O.
    Robins, Harlan
    Pierce, Robert H.
    Elashoff, David A.
    Robert, Caroline
    Ribas, Antoni
    NATURE, 2014, 515 (7528) : 568 - +
  • [3] PD-1 blockade induces responses by inhibiting adaptive immune resistance
    Paul C. Tumeh
    Christina L. Harview
    Jennifer H. Yearley
    I. Peter Shintaku
    Emma J. M. Taylor
    Lidia Robert
    Bartosz Chmielowski
    Marko Spasic
    Gina Henry
    Voicu Ciobanu
    Alisha N. West
    Manuel Carmona
    Christine Kivork
    Elizabeth Seja
    Grace Cherry
    Antonio J. Gutierrez
    Tristan R. Grogan
    Christine Mateus
    Gorana Tomasic
    John A. Glaspy
    Ryan O. Emerson
    Harlan Robins
    Robert H. Pierce
    David A. Elashoff
    Caroline Robert
    Antoni Ribas
    Nature, 2014, 515 : 568 - 571
  • [4] RADIOFREQUENCY ABLATION PLUS PD-1 BLOCKADE SHAPES THE ANTITUMOR MICROENVIRONMENT
    Li, Shuang
    Zeng, Xuezhen
    Song, Tongtong
    Zhao, Xiao
    Peng, Sui
    Kuang, Ming
    Mei, Jie
    GASTROENTEROLOGY, 2024, 166 (05) : S1718 - S1718
  • [5] PD-1 blockade unblocks immune responses to vaccination
    Kedzierska, Katherine
    Nguyen, Thi H. O.
    NATURE IMMUNOLOGY, 2022, 23 (08) : 1135 - 1137
  • [6] PD-1 blockade unblocks immune responses to vaccination
    Katherine Kedzierska
    Thi H. O. Nguyen
    Nature Immunology, 2022, 23 : 1135 - 1137
  • [7] Combination therapy of reovirus and PD-1 blockade effectively establishes tumor control via innate and adaptive immune responses
    Rajani, Karishma
    Parrish, Christopher
    Shim, Kevin
    Ilett, Liz
    Errington-Mais, Fiona
    Thompson, Jill
    Kottke, Tim
    Maria-Diaz, Rosa
    Selby, Peter
    Pandha, Hardev
    Harrington, Kevin
    Melcher, Alan
    Coffey, Matt
    Zaidi, Shane
    Vile, Richard
    CANCER RESEARCH, 2015, 75
  • [8] Combination Therapy of Reovirus and PD-1 Blockade Effectively Establishes Tumor Control Via Innate and Adaptive Immune Responses
    Rajani, Karishma
    Shim, Kevin
    Parrish, Christopher
    Ilett, Liz
    Kottke, Tim
    Pulido, Jose
    Thompson, Jill
    Pandha, Hardev
    Harrington, Kevin
    Melcher, Alan
    Errington, Fiona
    Diaz, Rosa
    Coffey, Matt
    Zaidi, Shane
    Vile, Richard
    MOLECULAR THERAPY, 2015, 23 : S30 - S30
  • [9] Loss of Tumor Intrinsic RIPK1, Antitumor Immune Responses, and the Efficacy of PD-1 Blockade
    Teng, F.
    Wang, P.
    Li, Y.
    Yuan, J.
    Yin, T.
    Shi, X.
    Xu, J.
    Liu, C.
    Yu, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E403 - E403
  • [10] Predicting Tumor Response to PD-1 Blockade
    Ding, Li
    Chen, Feng
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (05): : 477 - 479
12345